C. Bourassa

发表

Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy

L. Stamatatos, D. Kaufmann, P. Uchil, 2021, Immunity.

Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound

J. Sodroski, J. Richard, Amos B. Smith, 2022, bioRxiv.

An S1 subunit vaccine and combination adjuvant (COVAC-1) elicits robust protection against SARS-CoV-2 challenge in African green monkeys

J. Strong, J. Audet, Zachary Schiffman, 2022, bioRxiv.

SARS-CoV-2 Accessory Protein ORF8 Decreases Antibody-Dependent Cellular Cytotoxicity

J. Richard, H. Medjahed, G. Gendron-Lepage, 2022, bioRxiv.

Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen

D. Vézina, V. Martel-Laferrière, D. Kaufmann, 2022, Cell reports.

Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset

V. Martel-Laferrière, D. Kaufmann, C. Tremblay, 2021, bioRxiv.

Live imaging of SARS-CoV-2 infection in mice reveals neutralizing antibodies require Fc function for optimal efficacy

L. Stamatatos, D. Kaufmann, P. Uchil, 2021, bioRxiv.

Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset

V. Martel-Laferrière, D. Kaufmann, C. Tremblay, 2021, Cell Reports Medicine.

Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients

V. Martel-Laferrière, D. Kaufmann, C. Tremblay, 2022, iScience.

A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile

V. Martel-Laferrière, D. Kaufmann, C. Tremblay, 2022, bioRxiv.

Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2

D. Vézina, M. Pazgier, J. Richard, 2022, Viruses.

Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection

D. Kaufmann, S. Anand, H. Medjahed, 2022, Viruses.

SARS-CoV-2 Spike Expression at the Surface of Infected Primary Human Airway Epithelial Cells

J. Richard, Shilei Ding, S. Anand, 2021, Viruses.

Indoline CD4-mimetic Compounds Mediate Potent and Broad HIV-1 Inhibition and Sensitization to Antibody-dependent Cellular Cytotoxicity

J. Sodroski, W. Hendrickson, C. Abrams, 2023, bioRxiv.

Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen

D. Vézina, V. Martel-Laferrière, D. Kaufmann, 2021, bioRxiv.

Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses

D. Vézina, V. Martel-Laferrière, D. Kaufmann, 2021, Cell Host and Microbe.

Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial

Kelly A. Fusco, Maria Cristina Lopes, D. Devine, 2021, Nature Medicine.

Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality

J. Richards, D. Kaufmann, A. Dyachenko, 2021, medRxiv.

A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses

D. Vézina, L. Stamatatos, V. Martel-Laferrière, 2021, Cell Host & Microbe.

Modulating HIV-1 envelope glycoprotein conformation to decrease the HIV-1 reservoir.

J. Sodroski, D. Kaufmann, B. Hahn, 2021, Cell host & microbe.

SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses

D. Vézina, V. Martel-Laferrière, D. Kaufmann, 2021, bioRxiv.

A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses

D. Vézina, L. Stamatatos, V. Martel-Laferrière, 2021, bioRxiv.

Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120.

D. Kaufmann, M. Pazgier, W. Tolbert, 2023, Cell chemical biology.

A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses

Justine C. Williams, E. Wherry, V. Martel-Laferrière, 2022, Cell Reports.

Temsavir Modulates HIV-1 Envelope Conformation by Decreasing Its Proteolytic Cleavage

J. Richard, H. Medjahed, G. Gendron-Lepage, 2023, Viruses.

Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen

D. Vézina, V. Martel-Laferrière, D. Kaufmann, 2022, Cell reports.

Indoline CD4-mimetic compounds mediate potent and broad HIV-1 inhibition and sensitization to antibody-dependent cellular cytotoxicity

J. Sodroski, W. Hendrickson, C. Abrams, 2023, bioRxiv.

Temsavir Treatment of HIV-1-Infected Cells Decreases Envelope Glycoprotein Recognition by Broadly Neutralizing Antibodies

D. Vézina, J. Richard, S. Anand, 2022, mBio.

Antigenicity of the Mu (B.1.621) and A.2.5 SARS-CoV-2 Spikes

J. Richard, H. Medjahed, G. Gendron-Lepage, 2022, Viruses.

Impact of HIV-1 Vpu-mediated downregulation of CD48 on NK-cell-mediated antibody-dependent cellular cytotoxicity

F. Kirchhoff, B. Hahn, J. Richard, 2023, mBio.

Structural and Functional Characterization of Indane-Core CD4-Mimetic Compounds Substituted with Heterocyclic Amines.

W. Hendrickson, C. Abrams, J. Richard, 2022, ACS medicinal chemistry letters.

Impact of HIV-1 Vpu-mediated downregulation of CD48 on NK-cell-mediated antibody-dependent cellular cytotoxicity

F. Kirchhoff, B. Hahn, J. Richard, 2023, mBio.

Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity

D. Vézina, D. Kaufmann, E. Bareke, 2023, medRxiv.

Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission

M. Pazgier, Shilei Ding, H. Medjahed, 2024, bioRxiv.

An S1 subunit vaccine and combination adjuvant (COVAC-1) elicits robust protection against SARS-CoV-2 challenge in African green monkeys

J. Strong, J. Audet, Zachary Schiffman, 2022, bioRxiv.